| Recruiting | Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea NCT07285785 | Bausch Health Americas, Inc. | Phase 4 |
| Recruiting | Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI) NCT06709521 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 4 |
| Completed | EFFICACY OF PROLONGED INFUSION MEROPENEM IN CRITICALLY ILL PAEDIATRIC INTENSIVE CARE PATIENTS NCT07122596 | Pakistan Navy Station Shifa Hospital | Phase 4 |
| Completed | Safety of Intravenous Apramycin in Adults NCT05590728 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777) NCT05645757 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Unknown | Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infe NCT04479657 | Zhong Wang | EARLY_Phase 1 |
| Completed | A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam NCT03978091 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Completed | Intravenous Fosfomycin Pharmacokinetics Study NCT03910673 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Minocycline Pharmacokinetics (ACUMIN) NCT03369951 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 4 |
| Completed | Impact of qSOFA Calculation on the Timing of Antimicrobial Therapy in the Emergency Department NCT03299894 | Centre Hospitalier Régional d'Orléans | N/A |
| Completed | Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infect NCT02794831 | Nantes University Hospital | — |
| Unknown | Study of Tigecycline Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy(CRRT) NCT02931526 | Zhujiang Hospital | — |
| Completed | Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites NCT02436876 | Microbion Corporation | Phase 2 |
| Completed | Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck Canc NCT02753387 | Rennes University Hospital | Phase 3 |
| Completed | Grinding Versus Standard Methods for the Treatment of Per-operative Bacteriological Samples Associated With Os NCT02598141 | Centre Hospitalier Universitaire de Nīmes | N/A |
| Completed | Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis NCT02914132 | ExThera Medical Corporation | N/A |
| Unknown | Elimination of Antibiotics During Citrate-anticoagulated Continuous-veno-venous-haemodialysis NCT02533609 | Heinrich-Heine University, Duesseldorf | — |
| Completed | Improved Adherence to C. Difficile Isolation Protocols Through Improved Education Methods NCT02375477 | Case Comprehensive Cancer Center | N/A |
| Completed | Pharmacokinetics and Safety of Solithromycin in Adolescents and Children NCT02268279 | Melinta Therapeutics, Inc. | Phase 1 |
| Completed | Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm NCT02294175 | North Florida Foundation for Research and Education | N/A |
| Completed | Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections NCT02052388 | Cellceutix Corporation | Phase 2 |
| Completed | Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition NCT01817075 | Children's Oncology Group | Phase 3 |
| Completed | Preventing Bacterial and Viral Infections Among Injection Drug Users NCT01892358 | Butler Hospital | N/A |
| Completed | Milk Ingredients and Resistance Against E-coli-induced GastroEnteritis (MIRAGE) NCT01800396 | NIZO Food Research | N/A |
| Completed | Characterizing and Comparing the Profile of Microorganisms From Specific Body Sites and Environmental Surfaces NCT01803100 | Duke University | — |
| Completed | Increase in Procalcitonin Kinetics May be a Good Indicator of Starting Empirical Antibiotic Treatment in Criti NCT02311816 | Domonkos Trásy | — |
| Completed | The Effect of Probiotics on E. Coli-induced Gastroenteritis NCT01709266 | NIZO Food Research | N/A |
| Completed | Contribution of Real Time Analyses of CARdio-RESpiratory Signals to the Diagnosis of Infection in PREterM Infa NCT01611740 | Rennes University Hospital | — |
| Completed | : Bacterial Infections in Injecting Drug Users NCT04550767 | University Hospital, Montpellier | — |
| Completed | Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offs NCT01446289 | Novartis | Phase 2 |
| Completed | Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoin NCT01371656 | Children's Oncology Group | Phase 3 |
| Completed | Meropenem Plasma Concentration Measurements at the Pediatric Medical Ward, Oslo University Hospital, Rikshospi NCT01289249 | Oslo University Hospital | — |
| Completed | Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg NCT01271998 | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 1 |
| Completed | Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction NCT01244698 | Stony Brook University | Phase 4 |
| Completed | Neutrophil CD64 and Procalcitonin as Novel Biomarkers for Postoperative Infections NCT01250574 | University Hospital, Akershus | — |
| Completed | The Effect of Probiotics on E. Coli Gastroenteritis NCT01225042 | NIZO Food Research | N/A |
| Completed | Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection NCT01173575 | Infectopharm Arzneimittel GmbH | — |
| Completed | Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients NCT01156077 | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 1 |
| Completed | Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease NCT01012089 | University of Oklahoma | N/A |
| Completed | Cerebral Antibiotics Distribution After Acute Brain Injury NCT01059890 | Poitiers University Hospital | Phase 1 |
| Completed | Retrospective Examination of Initial Care of Severe Bacterial Infections of the Child NCT01485705 | Nantes University Hospital | N/A |
| Withdrawn | Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients NCT00430469 | AM-Pharma | Phase 1 / Phase 2 |
| Completed | Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate NCT00939562 | Pfizer | Phase 4 |
| Unknown | Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community NCT00765778 | Tel-Aviv Sourasky Medical Center | — |
| Completed | Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy NCT00915213 | University of California, Irvine | — |
| Completed | Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months NCT00800488 | Assistance Publique - Hôpitaux de Paris | — |
| Terminated | Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection NCT00407147 | Brahms AG | Phase 4 |
| Completed | Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infec NCT00633152 | Forest Laboratories | Phase 2 |
| Terminated | Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416 NCT00680485 | GlaxoSmithKline | Phase 1 |
| Completed | Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Sou NCT00692848 | St. Justine's Hospital | N/A |
| Terminated | Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU NCT00307099 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | Antiseptic Use and Dressing Application NCT00389558 | Maternite Regionale Universitaire | Phase 4 |
| Completed | Bacterial Pulmonary Infection in PICU NCT00271531 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria NCT00275327 | University of Pittsburgh | — |
| Completed | Effect of Chlorhexidine Cleansing on Skin Flora of Newborns in Nepal NCT00271440 | Johns Hopkins Bloomberg School of Public Health | Phase 1 / Phase 2 |
| Completed | An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm NCT00760279 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 1 |
| Completed | Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs) NCT00254696 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Completed | Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia NCT02544230 | Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne | — |
| Completed | Etiology, Prevention and Treatment of Neonatal Infections in the Community NCT00198627 | Johns Hopkins Bloomberg School of Public Health | N/A |
| Unknown | Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants NCT00189384 | Aga Khan University | Phase 3 |
| Completed | Leukocyte Depletion of Autologous Whole Blood NCT00176124 | Heidelberg University | Phase 4 |
| Completed | Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis NCT00004829 | FDA Office of Orphan Products Development | Phase 3 |